Go Pro

Mizuho Issues Pessimistic Forecast for Nutrien (NYSE:NTR) Stock Price

Nutrien logo with Basic Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Mizuho cut its price target on Nutrien from $77 to $75 while keeping a neutral rating, implying about 10.87% upside from the previous close.
  • Analyst sentiment remains generally positive overall, with Nutrien holding an average “Moderate Buy” rating and an average price target of $82.00. Several firms recently raised ratings or targets, including Raymond James, JPMorgan, TD Securities, and Scotiabank.
  • Nutrien posted stronger-than-expected quarterly results, reporting EPS of $0.51 versus $0.48 expected and revenue of $6.05 billion, up 18.5% year over year. The stock was trading up 3.4% at the time of the report.
  • Interested in Nutrien? Here are five stocks we like better.

Nutrien (NYSE:NTR - Get Free Report) had its price target reduced by Mizuho from $77.00 to $75.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has a "neutral" rating on the stock. Mizuho's target price points to a potential upside of 10.87% from the company's previous close.

Several other research analysts also recently weighed in on the company. Raymond James Financial upgraded Nutrien from a "market perform" rating to an "outperform" rating and boosted their target price for the stock from $74.00 to $90.00 in a research note on Tuesday, May 5th. JPMorgan Chase & Co. increased their price target on Nutrien from $78.00 to $80.00 and gave the company an "overweight" rating in a research note on Monday, May 11th. TD Securities reissued a "buy" rating on shares of Nutrien in a report on Wednesday, May 6th. National Bank Financial set a $76.00 price target on Nutrien and gave the stock an "outperform" rating in a research note on Monday. Finally, Scotiabank upgraded shares of Nutrien from a "sector perform" rating to a "sector outperform" rating and set a $80.00 price objective on the stock in a report on Tuesday, June 30th. Fourteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, Nutrien presently has an average rating of "Moderate Buy" and an average price target of $82.00.

View Our Latest Analysis on Nutrien

Nutrien Trading Up 3.4%

NYSE:NTR opened at $67.64 on Tuesday. The stock has a market capitalization of $32.42 billion, a price-to-earnings ratio of 13.78, a PEG ratio of 0.63 and a beta of 0.62. Nutrien has a 52 week low of $53.03 and a 52 week high of $85.36. The company has a quick ratio of 0.59, a current ratio of 1.24 and a debt-to-equity ratio of 0.35. The firm has a 50 day moving average of $67.23 and a 200 day moving average of $69.77.

Nutrien (NYSE:NTR - Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.03. Nutrien had a net margin of 8.58% and a return on equity of 8.84%. The business had revenue of $6.05 billion for the quarter, compared to analyst estimates of $5.30 billion. During the same period in the previous year, the company earned $0.11 earnings per share. The business's revenue for the quarter was up 18.5% on a year-over-year basis. As a group, sell-side analysts anticipate that Nutrien will post 5.19 earnings per share for the current fiscal year.

Institutional Trading of Nutrien

Several institutional investors and hedge funds have recently bought and sold shares of the business. Swiss Life Asset Management Ltd raised its stake in shares of Nutrien by 23.6% during the 3rd quarter. Swiss Life Asset Management Ltd now owns 79,770 shares of the company's stock valued at $4,691,000 after buying an additional 15,230 shares during the last quarter. MH & Associates Securities Management Corp ADV acquired a new position in shares of Nutrien in the 4th quarter valued at about $1,967,000. Hudson Bay Capital Management LP boosted its stake in shares of Nutrien by 190.3% in the third quarter. Hudson Bay Capital Management LP now owns 116,312 shares of the company's stock worth $6,829,000 after buying an additional 76,244 shares during the last quarter. TD Waterhouse Canada Inc. boosted its stake in shares of Nutrien by 4.2% in the fourth quarter. TD Waterhouse Canada Inc. now owns 2,359,022 shares of the company's stock worth $145,257,000 after buying an additional 94,510 shares during the last quarter. Finally, Vanguard Group Inc. grew its holdings in Nutrien by 2.2% during the fourth quarter. Vanguard Group Inc. now owns 22,463,277 shares of the company's stock worth $1,386,546,000 after acquiring an additional 479,834 shares during the period. 63.10% of the stock is currently owned by institutional investors and hedge funds.

Nutrien Company Profile

(Get Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien's business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

See Also

Analyst Recommendations for Nutrien (NYSE:NTR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Nutrien Right Now?

Before you consider Nutrien, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.

While Nutrien currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines